Why Capricor Therapeutics Stock Is Soaring Tuesday
Capricor Therapeutics Inc (NASDAQ:CAPR) shares are trading higher Tuesday after the company announced intent to file a ...
Capricor surges on plans to seek FDA approval for lead asset
Shares of Capricor Therapeutics (NASDAQ:CAPR) surged in the morning hours on Tuesday after the cell therapy developer ...
Capricor: DMD Treatment Focus With Deramiocel Is Likely To Pay Off
Capricor announced it intends to file a BLA for deramiocel for treatment of patients with DMD cardiomyopathy. Click here to ...
bovnews15h
Capricor Therapeutics Inc (CAPR) Stock Trading Recap
In recent trading, Capricor Therapeutics Inc (CAPR) stock price has shown some volatility, fluctuating 101.95% over the last five trades and 111.45% over the past 30 trades. This represents a notable ...
Capricor (CAPR) Surges 18.2%: Is This an Indication of Further Gains?
Capricor Therapeutics (CAPR) shares rallied 18.2% in the last trading session to close at $5.97. This move can be attributable to notable volume with a higher number of shares being traded than in a ...
Capricor Therapeutics Shares Rise in Premarket on Plans to File Application for Deramiocel
Capricor Therapeutics shares rose in premarket trading Tuesday after the company said it plans to file a biologics license application for Deramiocel, its Duchenne muscular dystrophy cardiomyopathy ...
Wave Life And Capricor Surge Forward With Hope - Are These Stocks In Your Portfolio?
Duchenne muscular dystrophy, or DMD, is a severe genetic disorder, typically affecting males, and is characterized by progressive ...
Capricor Therapeutics, Inc.(纳斯达克:CAPR)的股票上涨了31%，但其业务仍然落后于行业板块。
Capricor Therapeutics, Inc. (NASDAQ:CAPR) shareholders have had their patience rewarded with a 31% share price jump in the ...
Buy Rating Affirmed for Capricor Therapeutics on Promising DMD-cardiomyopathy Treatment Prospects
Joseph Pantginis, an analyst from H.C. Wainwright, reiterated the Buy rating on Capricor Therapeutics (CAPR – Research Report). The ...
Nvidia, Alibaba, Capricor Therapeutics, TSMC, Tesla: Why These 5 Stocks Are On Investors' Radars Today
On Tuesday, major U.S. indices closed higher, with the Dow Jones Industrial Average gaining 0.2% to reach 42,208.22.
Capricor Therapeutics计划于10月提交DMD治疗的BLA申请
SAN DIEGO - 专注于细胞和外泌体疗法治疗罕见疾病的生物技术公司Capricor Therapeutics (NASDAQ: CAPR)宣布计划向美国食品和药物管理局(FDA)提交其主要产品候选药物deramiocel的生物制品许可申请(BLA)，用于治疗杜氏肌营养不良症(DMD)患者的心肌病。该公司预计将于2024年10月开始滚动提交流程，并在年底前完成。 这一决定是在最近与FDA讨论后 ...
Maxim上调Capricor股票目标价并维持买入评级，因FDA最新进展
Maxim Group调整了对Capricor Therapeutics (NASDAQ: CAPR)的展望,将该公司股票的目标价从之前的12.00美元大幅上调至25.00美元。该公司维持对该股的买入评级。 此次调整是在Capricor宣布计划为其细胞疗法产品deramiocel提交生物制品许可申请(BLA)之后做出的。该产品旨在治疗与杜氏肌营养不良症(DMD)相关的心肌病。 在宣布与美国食品和药 ...